More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
31 May, 2026, 01.34 PM IST
Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
17 May, 2026, 06.20 AM IST
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
08 May, 2026, 10.19 PM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
22 Apr, 2026, 03.31 PM IST
Granules India shares in focus on acquiring Swiss firm for Rs 192 crGranules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The ...
24 Feb, 2025, 08.27 AM IST
Granules acquires Swiss firm for Rs 192 cr; forays into CDMO spaceGranules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acqu...
21 Feb, 2025, 10.52 PM IST
Scientists discover small proteins which may reduce inflammation caused by COVID-19The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring sma...
05 Jul, 2020, 02.40 PM IST
IIT Guwahati researchers claim new method to delay onset of Alzheimer'sThe reasearch team proposed the application of a low-voltage electric field, and the use of ‘trojan peptides’ to arrest aggregation of neur...
20 May, 2020, 03.43 PM IST
Synthetic peptide can repair cognitive decline, help treat Alzheimer's earlyThese peptides can block amyloid beta aggregation at the early and most toxic stage when oligomers form.
23 Apr, 2019, 11.32 AM IST
- Blood protein paves way for potential Alzheimer's drug design
Kolkata, Dec 9 (IANS) Opening up new horizons in designing drugs for Alzheimer's disease, Indian researchers have discovered that fibrinoge...
09 Dec, 2016, 10.20 AM IST
Indian-American scientist Arnab De wins Springer Theses AwardAn Indian-American scientist has received this prestigious award for his outstanding research on developing transgenic mice to study a crit...
28 May, 2016, 12.34 PM IST
Aurobindo Pharma targets a revenue of over $3 billion by 2017-18Aurobindo Pharma is targeting a revenue of over $3 billion (over Rs 19,800 crore) by 2017-18 and plans to expand its basket with drugs to t...
24 Aug, 2015, 04.00 AM IST
Self-assembling anti-cancer molecules created in minutesResearchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of th...
04 Aug, 2014, 03.40 PM IST
Indian scientist develops potential non-insulin diabetes drugArnab De, a PhD in Microbiology and Immunology from Columbia University, has developed the non-insulin drug candidate in collaboration with...
02 Apr, 2014, 03.16 PM IST
- Biocon joins hands with US co Amylin for diabetes drug
Biocon has put the development of its diabetes drug on the fast track by teaming up with US-based biopharma player Amylin Pharmaceuticals.
12 Sep, 2009, 12.11 AM IST
- Indian drug cos prepare a peptide mix
As blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
14 Jun, 2007, 01.49 AM IST